Who owns Avita Therapeutics Inc?
- Ticker: RCEL
- CUSIP Number: 05380c102
Tip: Access positions for across all investors
Analyze quarterly positions in Avita Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Avita Therapeutics stock
Who bought or sold Avita Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 1.4M | $7.0M | -6% | Sep 2025 |
|
| BlackRock | 1.1M | $5.8M | -40% | Sep 2025 |
|
| State Street Corporation | 423k | $2.2M | -20% | Sep 2025 |
|
| Geode Capital Management | 332k | $1.7M | -46% | Sep 2025 |
|
| Morgan Stanley | 222k | $1.2M | 100% | Jun 2025 |
|
| Northern Trust | 173k | $883k | -33% | Sep 2025 |
|
| Millennium Management | 133k | $678k | -64% | Sep 2025 |
|
| AQR Capital Management | 119k | $610k | 444% | Sep 2025 |
|
| Bridgeway Capital Management | 118k | $603k | 214% | Sep 2025 |
|
| Goldman Sachs Group | 117k | $597k | -30% | Sep 2025 |
|
| Divisadero Street Capital Management | 100k | $511k | 100% | Sep 2025 |
|
| Hrt Financial | 93k | $475k | 100% | Sep 2025 |
|
| Jane Street | 89k | $455k | 3% | Sep 2025 |
|
| UBS Group | 75k | $385k | -82% | Sep 2025 |
|
| National Bank Of Canada /fi/ | 59k | $301k | 100% | Sep 2025 |
|
| Citadel Advisors | 53k | $270k | -53% | Sep 2025 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 48k | $244k | 234% | Sep 2025 |
|
| Charles Schwab Investment Management | 46k | $233k | -47% | Sep 2025 |
|
| Marshall Wace | 43k | $219k | -44% | Sep 2025 |
|
| Nuveen | 42k | $214k | -29% | Sep 2025 |
|
| Quantinno Capital Management | 42k | $212k | 228% | Sep 2025 |
|
| Rhumbline Advisers | 38k | $196k | -9% | Sep 2025 |
|
| Susquehanna International | 35k | $180k | -24% | Sep 2025 |
|
| Gabelli Funds | 35k | $179k | 0% | Sep 2025 |
|
| Bank of New York Mellon | 31k | $158k | -44% | Sep 2025 |
|
| Ameriprise Financial | 29k | $149k | -1% | Sep 2025 |
|
| IHT Wealth Management | 26k | $132k | -7% | Sep 2025 |
|
| Diadema Partners | 25k | $128k | 100% | Sep 2025 |
|
| XTX Topco | 25k | $127k | -14% | Sep 2025 |
|
| Macquarie Group | 21k | $110k | -18% | Sep 2025 |
|
| OMERS Administration Corporation | 21k | $107k | 100% | Sep 2025 |
|
| Alliancebernstein | 20k | $104k | 0% | Sep 2025 |
|
| Barclays | 20k | $100k | -58% | Sep 2025 |
|
| RMB Capital Management | 19k | $97k | 0% | Sep 2025 |
|
| Intech Investment Management | 12k | $64k | 10% | Sep 2025 |
|
| Hsbc Holdings | 10k | $52k | 100% | Sep 2025 |
|
| Wells Fargo & Company | 9.5k | $49k | -40% | Sep 2025 |
|
| Quest Partners | 9.4k | $48k | 0% | Sep 2025 |
|
| Farther Finance Advisors | 6.3k | $32k | 100% | Sep 2025 |
|
| Tower Research Capital | 6.3k | $32k | 51% | Sep 2025 |
|
| Mirae Asset Global Etfs Holdings | 5.7k | $29k | -62% | Sep 2025 |
|
| New York State Common Retirement Fund | 5.3k | $27k | 0% | Sep 2025 |
|
| Jpmorgan Chase & Co | 5.3k | $27k | -58% | Sep 2025 |
|
| Royal Bank of Canada | 4.5k | $26k | 5225% | Sep 2025 |
|
| Russell Investments | 3.6k | $19k | -22% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 2.9k | $15k | 10% | Sep 2025 |
|
| FMR | 2.8k | $15k | -38% | Sep 2025 |
|
| Summit Investment Advisors | 2.1k | $11k | 0% | Sep 2025 |
|
| Police & Firemen's Retirement System of New Jersey | 1.9k | $9.6k | 100% | Sep 2025 |
|
| California State Teachers Retirement System | 1.7k | $8.5k | 100% | Sep 2025 |
|
| Legal & General Group | 1.2k | $6.3k | -60% | Sep 2025 |
|
| Sound Income Strategies | 1.0k | $5.5k | 100% | Sep 2025 |
|
| Goss Wealth Management | 1.0k | $5.1k | 0% | Sep 2025 |
|
| Amalgamated Bank | 848.00 | $4.0k | 0% | Sep 2025 |
|
| Truvestments Capital | 693.00 | $3.5k | -44% | Sep 2025 |
|
| CWM | 658.00 | $3.0k | -4% | Sep 2025 |
|
| Capital Analysts | 652.00 | $3.0k | 0% | Sep 2025 |
|
| Deutsche Bank Aktiengesellschaft | 544.00 | $2.8k | -96% | Sep 2025 |
|
| Optiver Holding B.V. | 462.00 | $2.4k | 100% | Sep 2025 |
|
| SRS Capital Advisors | 441.00 | $2.3k | 100% | Sep 2025 |
|
| GAMMA Investing | 377.00 | $1.9k | 29% | Sep 2025 |
|
| SBI Securities | 197.00 | $1.0k | -20% | Sep 2025 |
|
| Jones Financial Companies, L.L | 134.00 | $697.001000 | 0% | Sep 2025 |
|
| Private Wealth Management Group | 111.00 | $567.998100 | -53% | Sep 2025 |
|
| EverSource Wealth Advisors | 76.00 | $388.002800 | 181% | Sep 2025 |
|
| Hartland & Co | 66.00 | $337.999200 | 100% | Sep 2025 |
|
| Parallel Advisors | 40.00 | $204.000000 | 0% | Sep 2025 |
|
| IFP Advisors | 33.00 | $167.999700 | 1550% | Sep 2025 |
|
| Sterling Capital Management | 30.00 | $153.000000 | -51% | Sep 2025 |
|
| Global Wealth Strategies & Associates | 20.00 | $102.000000 | 0% | Sep 2025 |
|
| Pnc Financial Services | 11.00 | $55.999900 | 100% | Sep 2025 |
|
| JPL Wealth Management | 5.00 | $26.000000 | 100% | Sep 2025 |
|
| True Wealth Design | 4.00 | $21.000000 | 100% | Sep 2025 |
|
| Quarry | 1.00 | $5.000000 | -100% | Sep 2025 |
|
Who sold out of Avita Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Opaleye Management | Jun 2025 | 390k | $2.1M |
| Jacobs Levy Equity Management | Jun 2025 | 138k | $731k |
| Wellington Management Company | Jun 2025 | 111k | $586k |
| D. E. Shaw & Co | Jun 2025 | 62k | $328k |
| Gabelli Securities | Jun 2025 | 20k | $106k |
| PharVision Advisers | Jun 2025 | 17k | $87k |
| MetLife Investment Advisors | Jun 2025 | 15k | $80k |
| Graham Capital Management | Jun 2025 | 14k | $74k |
| Manufacturers Life Insurance Company | Jun 2025 | 11k | $58k |
| Invesco | Jun 2025 | 11k | $58k |
| Virtu Financial | Jun 2025 | 11k | $55k |
| Meeder Asset Management | Jun 2025 | 6.5k | $34k |
| Lazard Asset Management | Jun 2025 | 3.0k | $15k |
| Us Bancorp | Jun 2025 | 1.7k | $9.0k |
| Raymond James Financial | Jun 2025 | 1.5k | $8.1k |
| Brian McDonald | Jun 2025 | 201.00 | $1.1k |
| Skopos Labs | Jun 2025 | 119.00 | $629.997900 |
| McIlrath & Eck | Jun 2025 | 100.00 | $529.000000 |